pleural effusion impact factor
Sjogren’s syndrome (SS) is an autoimmune disorder and can cause many organic changes. Although disease pathogenesis has not yet been fully elucidated, substantial data has been demonstrated for diagnosis. Over the past 15 years, two sets of criteria have been published.
New 2016 ACR/EULAR classification criteria for primary Sjogren’s syndrome (SS) have been developed and endorsed by the ACR. Pulmonary involvement in SS include xerotrachea, bronchial sicca, obstructive small airway disease, interstitial lung diseases, lymphproliferative lung disease, pulmonary hypertension, pleurites, pleural effusion, and thickened pleura. Cardiac involvement includes pericarditis, pericardial effusion, and atrioventricular conduction block. Read More>>>>>>>>
Pancreaticopleural fistula (PPF) is a rare complication of pancreatitis, occurring in 0.4% of patients with pancreatitis and in 4.5% of patients with pancreatic pseudocyst. Most of the PPF form by leak of pancreatic secretion from a pancreatic pseudocyst. Rare cases occur directly thru the leaking of a pancreatic duct . We present a case of PPF that was successfully treated with a pancreatic duct stent.
Case Description: A 34 year-old male with a past history of alcohol-induced chronic pancreatitis was admitted to our hospital with a three weeks course of dyspnea. Physical examination of the patients was notable for diminished air passage and dullness on percussion of left chest wall. Chest X-ray revealed massive pleural effusion on the left side that was confirmed by contrastenhanced CT of the chest. Read more>>>>>>>>>>>>>>>>>>